The 5th HIV Research for Prevention Conference (HIVR4P 2024) brought together over 1,300 experts in Lima, Peru, to discuss the latest advancements in HIV prevention. Long-acting injectables, like lenacapavir from Gilead Sciences, showed promising results and were highlighted as a potential game changer for the field.
allAfrica's Sethi Ncube was in Lima, Peru, for the 5th HIV Research for Prevention Conference, HIVR4P 2024, and reported from the only global scientific conference focused on the challenging and fast-growing field of HIV prevention research. Here she speaks with registered nurse Idah Mulala, who extended her passion far beyond the hospital and became a strong advocate for HIV prevention, particularly among adolescents and young people.
Lenacapavir’s potential to be a “game changer” in the HIV prevention landscape was emphasized throughout the conference. However, The implementation of post-exposure prophylaxis and pre-exposure prophylaxis was discussed at HIVR4P 2024. While PEP and PrEP have been successful in reducing HIV transmission, barriers to access persist, particularly in low- and middle-income countries.
Recognizing that people's preferences and needs change, the conference underscored the need for accessible, adaptable prevention tools that cater to these shifts. This is especially important for women and girls, who often face unique vulnerabilities to HIV acquisition. By prioritizing choice, HIV prevention efforts can be more responsive and inclusive.Despite remarkable progress in HIV prevention, one key tool remains elusive - a highly effective HIV vaccine.
HIV Prevention Long-Acting Injectables Lenacapavir Prep PEP
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
135 Entelect team members celebrate long service milestones in 2024In a landmark achievement, 135 Entelect employees have been recognised for their long service in 2024.
Read more »
Africa's Researchers' Crucial Role in Advancing HIV PreventionallAfrica's Sethi Ncube is in Lima, Peru, for the 5th HIV Research for Prevention Conference, HIVR4P 2024, and will report from the only global scientific conference focused on the challenging and fast-growing field of HIV prevention research.
Read more »
Africa: Time to Embrace HIV Prevention Tools While We Wait For The CureBlog - allAfrica's Sethi Ncube is in Lima, Peru, for the 5th HIV Research for Prevention Conference, HIVR4P 2024, reporting from the only global scientific conference focused on the challenging and fast-growing field of HIV prevention research.
Read more »
Africa's Researchers Playing Crucial Role in Advancing HIV Prevention #HIVR4P2024Africa is contributing to groundbreaking data from the PURPOSE 2 study, which explores twice-yearly lenacapavir for HIV prevention. This study, with participants from South Africa and Uganda , is one of the scientific highlights showcased at the 5th HIV Research for Prevention Conference, better known as HIVR4P 2024, in Lima, Peru.
Read more »
Africa: Rwanda's Economy Registers Strong Growth in Early 2024 Despite Persistent ChallengesRwanda's real GDP grew by 9.7% in the first quarter of 2024, exceeding the previous year's growth rate of 8.2%.
Read more »
Ballon d’Or 2024: Vinicius Jr, Rodri Overlooked As Argentina Boss Names ‘Forgotten’ Candidate2022 World Cup winning coach Lionel Scaloni 'ignored' Vinicius Junior and Rodri as he picked a 'forgotten' candidate for the 2024 Ballon d'Or Award.
Read more »